First Horizon Corporation’s Jazz Pharmaceuticals JAZZ Stock Holding History

First Horizon Corporation’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$9.88K	Buy	41 +34	+486%	+$7.45K	﹤0.01%	1124
2026 Q1	$1.32K	Hold	7	–	–	﹤0.01%	1325
2025 Q4	$1.19K	Buy	+7	New	+$1.07K	﹤0.01%	1371
2021 Q2	$3K	Buy	22 +12	+120%	+$2.08K	﹤0.01%	902
2021 Q1	$1K	Hold	10	–	–	﹤0.01%	989
2020 Q4	$1K	Hold	10	–	–	﹤0.01%	982
2020 Q3	$1K	Buy	+10	New	+$1.24K	﹤0.01%	947

Other funds holding JAZZ

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

BTW

Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return

PCM

Polaris Capital Management Boston, Massachusetts $1.06B AUM 40.82% 1-Year Est. Return

ACM

Argent Capital Management St Louis, Missouri $3.17B AUM 36.16% 1-Year Est. Return

Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

WCM

Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Perpetual Ltd Sydney, New South Wales, Australia $7B AUM 19.75% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

First Horizon Corporation's JAZZ Position: Q2 2026 in Review

First Horizon Corporation increased its Jazz Pharmaceuticals (JAZZ) stake by 486% in Q2 2026, buying an estimated $7.45K and bringing the position to 41 shares worth $9.88K. The position accounts for ﹤0.01% of the portfolio, ranked #1124.

First Horizon Corporation first reported a position in JAZZ in Q3 2020 and has held it in 7 quarters since. 203 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

First Horizon Corporation held 41 shares of Jazz Pharmaceuticals worth $9.88K as of Q2 2026.
First Horizon Corporation bought 34 Jazz Pharmaceuticals shares in Q2 2026, an estimated $7.45K.
Jazz Pharmaceuticals made up ﹤0.01% of First Horizon Corporation's portfolio in Q2 2026, its #1124 holding.
First Horizon Corporation first reported a position in Jazz Pharmaceuticals in Q3 2020 and has held it in 7 quarters since.
203 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on First Horizon Corporation's 13F filing for Q2 2026, filed 20 Jul 2026.